Outcomes of Surgical Management of Temporomandibular Joint Anterior Disc Displacement Without Reduction

NCT05478915 | Unknown

• 1 other identifier: Soh-Med-22-6-12
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

this study will be done to detect the best management of temporo-mandibular joint anterior disc displacement without reduction, for diagnosis, we use MRI on the TMJ to detect status of the disc and joint space, for management, we try to select best operation as discopexy, discectomy with or without replacement, and we follow up the patients and detect side effects and effect for each operation

Conditions

Temporomandibular Joint Disc Displacement, Without Reduction

Outcome Measures

Primary Outcomes (1)

• pain of the TMJ

  degree of pain related to TMJ measured by Visual Analogue Scoring System from 0 to 10 where 0 means no pain and 10 means severe unbearable pain

  6 months

Secondary Outcomes (1)

• mouth openning

  3 months

Study Arms (1)

patients with TMJ anterior disc displacement

EXPERIMENTAL

patients had clinically limited mouth opening and by MRI we found anterior disc displacement

Procedure: discectomy of the TMJ disc; Procedure: TMJ discopexy

Interventions

discectomy of the TMJ disc PROCEDURE

removal of the TMJ disc

patients with TMJ anterior disc displacement

TMJ discopexy PROCEDURE

fixation of the TMJ disc

patients with TMJ anterior disc displacement

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• This study will include patients diagnosed as anterior disc displacement without reduction based on clinical manifestations and MRI.

You may not qualify if:

• o Patients with severe osteoarthritic changes of the condyle and glenoid fossa.
• Patients with bony ankylosis.
• Patients with infection or tumors around joint area.
• Patients with previous TMJ surgery.
• Any patient with systemic inflammatory disease or myopathic disease affecting TMJ such as Rheumatoid Arthritis And Systemic Lupus Erythromatosis.
• Patients unfit for intervention.
• Patients who refused to share in the study.

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

Location

Study Officials

• Kamal M El- sharkawy, proffessor

  sohag univesity hospitals

  STUDY DIRECTOR

Central Study Contacts

Mohamed A ALI, lecturer

CONTACT

01093459925; mohamed.abdelaal@med.sohag.edu.eg

Kamal M Hassanein, professor

CONTACT

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: assistant lecturer of maxillofacial surgery

Study Record Dates

• First Submitted: June 22, 2022
• First Posted: July 28, 2022
• Study Start: August 13, 2023
• Primary Completion: August 1, 2025
• Study Completion: August 1, 2025
• Last Updated: April 12, 2023

Record last verified: 2023-04

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)